Arbutus Biopharma director Tram Tran resigns effective Feb 26, 2023 for public service role

Arbutus Biopharma Corp

Dr. Tram Tran resigned from the Board effective Feb 26, 2023, to begin a public service role on Feb 27.
She joined the Board in Nov 2021 and served on the Executive Compensation and Human Resources Committee.
Resignation is not due to any disagreement with the company; board will immediately search for a replacement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tram Tran

Director

ABUS · Arbutus Biopharma Corp

Effective: 2023-02-26
Filed: January 27, 2023, 6:59 PM ET

On January 23, 2023, Tram Tran, M.D. notified Arbutus Biopharma Corporation (the “Company”) of her decision to resign from the Board of Directors of the Company and all committees thereof, effective as of February 26, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tram Tran resigned as Director at Arbutus Biopharma Corp.

Action: resigned
Role: Director

Exact text from the filing

On January 23, 2023, Tram Tran, M.D. notified Arbutus Biopharma Corporation (the “Company”) of her decision to resign from the Board of Directors of the Company and all committees thereof, effective as of February 26, 2023.

View on SEC.gov

Arbutus Biopharma Corp filing history →

Source: SEC EDGAR

accession 0001171843-23-000518

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.